Kendomycin
Cat. No.：YN320547
| 产品名称: | Kendomycin |
| CAS No.: | 183202-73-5 |
| Chemical Name: | (13E)-6R,7S,8R,9R,10,11,12S,15,16S,17,18S,19S-dodecahydro-4,7,19-trihydroxy-2,6,8,12,14,16,18-heptamethyl-1,19:5R,9-diepoxybenzocyclooctadecen-3(5H)-one |
| Synonyms: | (-)-TAN2162 |
| 分子量: | 486.64 |
| 分子式: | C₂₉H₄₂O₆ |
| SMILES: | OC(C1=O)=C([C@]([C@@H]([C@H]2O)C)([H])O[C@@](CC[C@@H]3C)([H])[C@@H]2C)C(C(O4)=C1C)=C[C@@]4([C@H](C[C@@H](C/C(C)=C/3)C)C)O |
| 存储: | Please store the product under the recommended conditions in theCertificate of Analysis. |
| 运输: | Room temperature in continental US; may vary elsewhere. |
| 产品描述: | Kendomycin ((−)-TAN 2162) 是一种聚酮类的抗生素 (antibiotic)，具有显著的抗菌和肿瘤细胞毒性活性。在低浓度下 (MIC: 5 μg/mL)，Kendomycin 能抑制耐甲氧西林金黄色葡萄球菌 (MRSA) 菌株 COL 的生长。Kendomycin 是内皮素受体 (endothelin receptor) 的拮抗剂和降钙素受体 (calcitonin receptor) 激动剂，具有抗骨质疏松作用。 |
| IC50和靶点: | |
| In Vitro: | |
| In Vivo: | |
| Clinical Trial: | |
| Solvent & Solubility: |
Bahnck, K.B., and Rychnovsky, S.D.Formal synthesis of (–)-kendomycin featuring a Prins-cyclization to construct the macrocycleJ. Am. Chem. Soc.130(39),13177-13181(2008)
